Trademark: 97492270
Status Date
Tuesday, November 7, 2023
Filing Date
Thursday, July 7, 2022
Published for Opposition
Tuesday, July 11, 2023
35 Retail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, biological preparations for developing T-cell based immunotherapy by building a series of proprietary tumor infiltrating lymphocyte; Retail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, medical cell function activating drugs for developing T-cell based immunotherapy by building a series of proprietary tumor infiltrating lymphocyte; Retail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, biological agents for treating cancer, namely, for treatment of solid tumor cancers by tumor infiltrating lymphocyte (TIL) therapy; Retail distributorship and wholesale distributorship services featuring pharmaceutical preparations, namely, tumor suppressors for treating cancer, namely, for treatment of solid tumor cancers by TIL therapy
Nov 7, 2023
Opposition Instituted No. 999999
Aug 4, 2023
Extension Of Time To Oppose Received
Jul 11, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 11, 2023
Published For Opposition
Jun 21, 2023
Notification Of Notice Of Publication E-Mailed
Jun 7, 2023
Approved For Pub - Principal Register
Jun 7, 2023
Examiner's Amendment Entered
Jun 7, 2023
Notification Of Examiners Amendment E-Mailed
Jun 7, 2023
Examiners Amendment E-Mailed
Jun 7, 2023
Examiners Amendment -Written
May 12, 2023
Teas/Email Correspondence Entered
May 12, 2023
Correspondence Received In Law Office
May 12, 2023
Teas Response To Office Action Received
Apr 27, 2023
Notification Of Non-Final Action E-Mailed
Apr 27, 2023
Non-Final Action E-Mailed
Apr 27, 2023
Non-Final Action Written
Apr 21, 2023
Assigned To Examiner
Jul 12, 2022
New Application Office Supplied Data Entered
Jul 11, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
